STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases
Melanoma is a skin cancer which can become metastatic, drug-refractory, and lethal if managed late or inappropriately. An increasing number of melanoma patients exhibits autoimmune diseases, either as pre-existing conditions or as sequelae of immune-based anti-melanoma therapies, which complicate pa...
Main Authors: | Stella Logotheti, Brigitte M. Pützer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/10/1448 |
Similar Items
-
Phosphorylated Forms of STAT1, STAT3 and STAT5 Are Expressed in Proliferating but Not Involuted Infantile Hemangioma
by: Lucy Sulzberger, et al.
Published: (2018-04-01) -
The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance
by: Agnieszka Witalisz-Siepracka, et al.
Published: (2022-07-01) -
Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
by: Alf Spitschak, et al.
Published: (2022-12-01) -
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation
by: Weiyuan Wang, et al.
Published: (2024-03-01) -
Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions
by: Alejandro Villarino, et al.
Published: (2016-03-01)